Rapport Therapeutics, Inc. Common Stock
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $36,067,000.
Profit Margin
| 2023 | 0 | -34.78M |
|---|
RAPP Income Statement (2023 – 2023)
| 2023 | |
|---|---|
Revenue | |
Revenue | 0 |
Cost of revenue | 112K |
Gross profit | -112K |
Operating exp. | |
Research and development | 27.99M |
Selling and marketing | -112K |
Total operating expenses | 36.06M |
Operating income | -36.17M |
Other income (expenses), net | 1.40M |
Income before tax | -34.77M |
Income tax expense | 10K |
Net income | -34.78M |
Earnings per share | |
Basic EPS | -0.21 |
Diluted EPS | -0.21 |